Laura Safar, MD, on Neuropsychiatric Disorders Among Patients With Multiple Sclerosis: The Role of Psychotropics
In this video, Laura T. Safar, MD, discusses psychotropic treatment as one of several potential tools for the management of neuropsychiatric disorders among patients with multiple sclerosis. She recently gave a talk on this topic at the Consortium for Multiple Sclerosis Centers Virtual Meeting.
- Safar LT. Use of psychotropics in MS: antidepressants, antianxiety agents, mood stabilizers, hypnotics, antipsychotics, and cognitive enhancers. Talk presented at: Consortium of Multiple Sclerosis Centers 2020 Virtual Meeting; May 28, 2020.
Laura T. Safar, MD, is an assistant professor of psychiatry at Harvard Medical School, and vice chair of psychiatry at Lahey Hospital & Medical Center in Massachusetts.